SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-21-011594
Filing Date
2021-11-12
Accepted
2021-11-12 16:06:39
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 hgen10qq3-2021.htm   iXBRL 10-Q 1174075
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7945
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7993
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4240
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4441
11 GRAPHIC clinpipe.jpg GRAPHIC 161932
  Complete submission text file 0001214659-21-011594.txt   4131328

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hgen-20210930.xsd EX-101.SCH 28836
7 XBRL CALCULATION FILE hgen-20210930_cal.xml EX-101.CAL 30404
8 XBRL DEFINITION FILE hgen-20210930_def.xml EX-101.DEF 98039
9 XBRL LABEL FILE hgen-20210930_lab.xml EX-101.LAB 202520
10 XBRL PRESENTATION FILE hgen-20210930_pre.xml EX-101.PRE 178849
12 EXTRACTED XBRL INSTANCE DOCUMENT hgen10qq3-2021_htm.xml XML 363434
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 211403424
SIC: 2834 Pharmaceutical Preparations